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Background: Hospital admissions for community-acquired infection are increasing rapidly in the United
Kingdom, particularly among older individuals, possibly reflecting an increasing prevalence of comorbid
conditions such as chronic kidney disease (CKD). This study describes associations between CKD
(excluding patients treated by dialysis or transplantation) and community-acquired infection incidence
among older people with diabetes mellitus.
Study Design: Retrospective cohort study using primary care records from the Clinical Practice Research
Datalink linked to Hospital Episode Statistics admissions data.
Setting & Participants: 191,709 patients 65 years or older with diabetes mellitus and no history of renal
replacement therapy, United Kingdom, 1997 to 2011.
Predictor: Estimated glomerular filtration rate (eGFR) and history of proteinuria.
Outcomes: Incidence of community-acquired lower respiratory tract infections (LRTIs, with pneumonia as a
subset) and sepsis, diagnosed in primary or secondary care, excluding hospital admissions from time at risk.
Measurements: Poisson regression was used to calculate incidence rate ratios (IRRs) adjusted for age,
sex, smoking status, comorbid conditions, and characteristics of diabetes. Estimates for associations of eGFR
with infection were adjusted for proteinuria, and vice versa.
Results: Strong graded associations between lower eGFRs and infection were observed. Compared with
patients with eGFRs$ 60 mL/min/1.73 m2, fully adjusted IRRs for pneumonia among those with eGFRs, 15,
15 to 29, 30 to 44, and 45 to 59 mL/min/1.73 m2 were 3.04 (95% CI, 2.42-3.83), 1.73 (95% CI, 1.57-1.92), 1.19
(95%CI, 1.11-1.28), and 0.95 (95%CI, 0.89-1.01), respectively. Associations between lower eGFRs and sepsis
were stronger, with fully adjusted IRRs up to 5.56 (95% CI, 3.90-7.94). Those associations with LRTI were
weaker but still clinically relevant at up to 1.47 (95% CI, 1.34-1.62). In fully adjusted models, a history of pro-
teinuria remained an independent marker of increased infection risk for LRTI, pneumonia, and sepsis (IRRs of
1.07 [95% CI, 1.05-1.09], 1.26 [95% CI, 1.19-1.33], and 1.33 [95% CI, 1.20-1.47]).
Limitations: Patients without creatinine results were excluded.
Conclusions: Strategies to prevent infection among people with CKD are needed.
Am J Kidney Dis. 66(1):60-68.ª 2015 The Authors. Published by Elsevier Inc. on behalf of the National Kidney
Foundation, Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
INDEX WORDS: Community-acquired infections; lower respiratory tract infections (LRTIs); pneumonia;
sepsis; non–dialysis-dependent chronic kidney disease (CKD); decreased renal function; estimated
glomerular filtration rate (eGFR); proteinuria; diabetes mellitus; aged; elderly; electronic health records.Hospitalization rates for infections in the UnitedKingdom are increasing rapidly, particularly
among older individuals: age-standardized hospital
admission rates for community-acquired pneumonia
more than doubled between 2000 and 2010.1,2 The
driving factors behind this increase are unclear, but a
higher prevalence of comorbid conditions in the aging
population has been suggested.1,2
One comorbid condition associated with hospitali-
zation for infection is chronic kidney disease (CKD).Departments of 1Non-communicable Disease Epide-
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Figure 1. Flowchart of study eligibility and participation.
*Baseline characteristics described in Table 1.
CKD and Infection Incidenceincreased risk of infection-related hospitalization
among patients with diabetes.6,7 CKD is a risk factor
for poor prognosis from infection, so this could be
driven by a higher chance of hospital admission for
patients with community-acquired infection if they
have CKD.8 It is unclear whether CKD is a risk factor
for higher incidence of infection in the community.
One large case-control study identiﬁed CKD as a risk
factor for incidence of community-acquired pneu-
monia in primary care, but relied on routine diagnosis
of CKD in the general population and did not exclude
patients receiving renal replacement therapy.9
There is a high prevalenceofCKDamongpeoplewith
diabetes, particularly older people.10-12 Patients with
diabetes are monitored regularly in primary care for
CKD, and this has been ﬁnancially incentivized in the
United Kingdom since 2004.13,14 Thus, studying people
with diabetes minimizes the potential for ascertainment
bias in estimating the association between CKD and
infection from routinely collected electronic health re-
cords. The subset of the UK population with diabetes
mellitus and aged 65 years or older is large and growing
and experiences a high burden of infection.15,16 This
population also is at higher risk of infectious complica-
tions such as acute kidney injury.17 If CKD is a risk
factor for infection incidence among older people with
diabetes, this could be important to health service plan-
ning, as well as to patients and their clinicians.
We aimed to describe, among older people with
diabetes, the associations between CKD (excluding
patients with a history of renal replacement therapy)
and community-acquired lower respiratory tract
infection (LRTI), pneumonia (as a subset of LRTI),
and sepsis. We used linked health records to identify
infections managed in primary or secondary care.
METHODS
Data Sources
We used the May 2011 data set of the Clinical Practice Research
Datalink (CPRD), a database of anonymized primary care medical
records comprising 12.8 million patient records at 627 practices in
the United Kingdom.18 Data include patient demographics, health
behaviors, test results, diagnoses, and prescriptions. The CPRD
population is representative of the general UK population and the
validity of recorded diagnoses generally is high.19,20 Linked data
are available for patients registered at consenting English prac-
tices. For linked patients, this study used linked data for all hos-
pital inpatient admissions to National Health Service hospitals in
England from Hospital Episodes Statistics (HES) and socioeco-
nomic status from the Ofﬁce for National Statistics.21,22
Study Population and Follow-up
All patients in CPRD at any point between April 1997 and
March 2011 with diabetes mellitus, aged 65 years or older, with at
least one valid serum creatinine result during the study period, and
with no history of renal replacement therapy were eligible. The
deﬁnition of diabetes was based on diagnostic Read codes.
“Deﬁnite” codes, for example, C10F.00 Type 2 diabetes mellitus,
were sufﬁcient evidence of diabetes. “Possible” codes, forAm J Kidney Dis. 2015;66(1):60-68example, 90LA.11 Diabetes monitored, required an antidiabetes
medication prescription for conﬁrmation. Full code lists were
published previously.15 Patients met eligibility criteria at the latest
date of diabetes diagnosis, 65th birthday, 1 year after practice
registration, practice fulﬁlling CPRD quality control standards, or
April 1, 1997. Their study entry date was their ﬁrst valid serum
creatinine result after the eligibility criteria were met. Patients left
the study at the earliest date of death, leaving the practice, last data
collection from the practice, renal replacement therapy (dialysis or
kidney transplantation), or March 31, 2011.
Deﬁnition of CKD
We estimated glomerular ﬁltration rate from primary care serum
creatinine test results, multiplied by 0.95 to correct for lack of
isotope-dilution mass spectrometry standardization, using the
CKD-EPI (CKD Epidemiology Collaboration) creatinine equa-
tion.23-25 We included adjustment for black ethnicity.26 To reduce
misclassiﬁcation of eGFR from variability in serum creatinine
results or acute illness, we used a last-carried-forward method,
with eGFR initially deﬁned using the creatinine result that marked
entry to the study and updated at each subsequent creatinine result
so that eGFR was always deﬁned by the single most recent
creatinine result, as previously performed by James et al.3,27 For
our main analyses, we used eGFR categories corresponding to
those used in diagnosis (,15, 15-29, 30-44, 45-59, and $60 mL/
min/1.73 m2).25 During the study period, many UK laboratories
did not report the speciﬁc value of eGFR results if they
were $60 mL/min/1.73 m2 and so we did not distinguish eGFR
categories . 60 mL/min/1.73 m2 in the main analysis. We
repeated the ﬁnal model including additional separate categories
for eGFR of 60 to 74, 75 to 89, and $90 mL/min/1.73 m2, with
patients with eGFRs of 75 to 89 mL/min/1.73 m2 as a reference
group.
Either a positive urine protein test result or a diagnosis of
proteinuric kidney disease in CRPD deﬁned onset of a history of
proteinuria. We excluded urine protein test results that occurred on
the same day as a diagnostic Read code for urinary tract infection.61
Table 1. Baseline Characteristics of Potentially Eligible Study Population by Baseline eGFR
No Scr (n 5 24,738)a eGFR $ 60 (n 5 124,521)b eGFR , 60 (n 5 68,952)b
Female sex 12,662 (51.2) 54,246 (43.6) 40,907 (59.3)
Age category
65-69 y 7,356 (29.7) 63,364 (50.9) 15,849 (23.0)
70-74 y 4,852 (19.6) 28,549 (22.9) 13,668 (19.8)
75-79 y 4,570 (18.5) 18,689 (15.0) 15,610 (22.6)
80-84 y 3,843 (15.5) 9,297 (7.5) 12,816 (18.6)
$85 y 4,117 (16.6) 4,622 (3.7) 11,009 (16.0)
SESc by practice
1: least deprived 3,839 (15.5) 21,818 (17.5) 12,341 (17.9)
2 4,269 (17.3) 22,312 (17.9) 12,515 (18.2)
3 5,101 (20.6) 26,136 (21.0) 13,962 (20.3)
4 6,037 (24.4) 28,355 (22.8) 15,500 (22.5)
5: most deprived 5,492 (22.2) 25,900 (20.8) 14,634 (21.2)
Smoking status
Current smoker 3,976 (16.1) 21,398 (17.2) 9,127 (13.2)
Ex-smoker 7,034 (28.4) 51,901 (41.7) 25,991 (37.7)
Nonsmoker 10,968 (44.3) 50,551 (40.6) 32,741 (47.5)
Missing 2,760 (11.2) 671 (0.5) 1,093 (1.6)
Comorbid conditions
Ischemic heart disease 6,381 (25.8) 30,743 (24.7) 23,308 (33.8)
Congestive heart failure 3,108 (12.6) 6,221 (5.0) 10,122 (14.7)
Hypertension 12,229 (49.4) 73,263 (58.8) 45,915 (66.6)
Cerebrovascular disease 4,169 (16.9) 13,157 (10.6) 11,500 (16.7)
Other dementia 1,350 (5.5) 1,651 (1.3) 1,889 (2.7)
Chronic lung disease 2,344 (9.5) 9,266 (7.4) 5,847 (8.5)
Antidiabetes medications
Insulin only 1,407 (5.7) 3,936 (3.2) 3,346 (4.9)
Oral medication only 9,811 (39.7) 54,635 (43.9) 27,169 (39.4)
Both insulin and oral 1,473 (5.6) 8,078 (6.5) 5,764 (8.4)
None recorded 12,047 (48.7) 57,872 (46.5) 32,673 (47.4)
Hemoglobin A1c
d
Good 7,256 (29.3) 58,177 (46.7) 31,026 (45.0)
Borderline 5,185 (21.0) 46,122 (37.0) 24,157 (35.0)
Poor 1,431 (5.8) 7,433 (6.0) 4,142 (6.0)
None recorded 10,866 (43.9) 12,789 (10.3) 9,627 (14.0)
Note: N 5 218,211. Values are given as number (percentage). Baseline is date of study entry for study participants (n 5 191,709)
and date of eligibility for study entry for patients not included in the study due to having no available Scr result or no available smoking
status. eGFRs expressed in mL/min/1.73 m2.
Abbreviations: eGFR, estimated glomerular filtration rate; Scr, serum creatinine; SES, socioeconomic status.
aThese patients had no Scr result available and hence were not included in study.
bThese patients had an Scr result available and were included in study unless smoking status was missing.
cIndex of multiple deprivation.
dGood, ,53 mmol/mol (,7%); borderline, 53-86 mmol/mol (7%-10%); poor, .86 mmol/mol (.10%).
McDonald et alWe did not count trace results as positive and checked records for
internal consistency.
Deﬁnition of Infections
We studied 3 acute community-acquired infections: LRTI
(which included diagnoses such as inﬂuenza and acute bronchitis),
pneumonia (as a subset of LRTI), and sepsis. Either diagnostic
Read codes in CPRD or any International Classiﬁcation of Dis-
eases, Tenth Revision code that formed the primary diagnostic
code on hospital admission in HES could deﬁne an infection. To
avoid overestimation from repeat attendances for the same infec-
tion, diagnostic codes recorded within 28 days of one another were
attributed to a single episode of infection, with index date deﬁned
by the ﬁrst diagnostic code and duration until 28 days after the last62diagnostic code. If any LRTI included a pneumonia code, the
pneumonia episode was considered to start from the ﬁrst instance
of the pneumonia code and end on the end date of the LRTI within
which it occurred. Any infection with onset date during an HES
hospitalization spell, within 14 days after hospital discharge, or
that included a code for postoperative infection was identiﬁed as a
hospital-acquired infection and excluded. These methods were
described in detail previously.15,28
Time at Risk
Patients were not at risk of a community-acquired infection
during an infection (community or hospital acquired), during an
HES hospitalization spell, or within 14 days following hospital
discharge, and these periods were removed from time at risk. TimeAm J Kidney Dis. 2015;66(1):60-68
Table 2. Prevalence of Markers of CKD at Baseline for Study
Participants
eGFR Proteinuria Absent History of Proteinuria Total
,15 307 234 (43.3) 541
15-29 3,373 1,205 (26.3) 4,578
30-44 14,857 3,417 (18.7) 18,274
45-59 38,672 5,794 (13.0) 44,466
60-74 52,168 6,726 (11.4) 58,894
75-89 41,446 5,379 (11.5) 46,825
$90 15,453 2,678 (14.8) 18,131
Total 166,276 25,433 (13.3) 191,709
Note: n 5 191,709. Markers of CKD are eGFR and history of
proteinuria. Values are given as number or number (row per-
centage). eGFR categories expressed in mL/min/1.73 m2.
Abbreviations: CKD, chronic kidney disease; eGFR, esti-
mated glomerular filtration rate.
CKD and Infection Incidenceat risk was calculated separately for each type of infection; a pa-
tient could be at risk of sepsis despite an ongoing LRTI, for
example.
Deﬁnition of Covariates
Age was deﬁned in 5-year age bands up to a ﬁnal category of 85
years or older. Socioeconomic status was assigned at practice level
using 2007 Ofﬁce for National Statistics estimates of the Index of
Multiple Deprivation, a composite area-level marker of depriva-
tion.22 Smoking status was identiﬁed as current, ex-smoker, or
nonsmoker from both HES and CPRD data. Smoking cessation
products were considered to indicate current smoking because
cessation success rates are low.29 The most recent smoking status
record by the study entry date deﬁned smoking status at baseline
when available; if not recorded, the ﬁrst subsequent record deﬁned
smoking status at baseline. Comorbid conditions (ischemic heart
disease, congestive cardiac failure, hypertension, cerebrovascular
disease, other dementia, and chronic lung disease) were deﬁned
using diagnostic CPRD Read codes. The ﬁrst diagnostic record at
any point in the patient’s records deﬁned onset of the condition.
Baseline hemoglobin A1c level was deﬁned by the most recent
hemoglobin A1c test result in CPRD prior to (or on) the study entry
date. Baseline diabetic medication history was deﬁned using
CPRD prescription records.
Data Analysis
Incidence rates were calculated for each infection using Poisson
regression with lexis expansions for age and a random-effects
model to adjust for multiple infection episodes. Analysis was
conducted separately for each type of infection (LRTI, pneumonia,
and sepsis) using 3 main regression models.
Negative proteinuria test results tend to be under-recorded in
primary care records.30 For comorbid conditions and proteinuria
status, absence of a positive record was treated as absence of
disease, and for hemoglobin A1c, absence of a recorded result was
included as a category of hemoglobin A1c status. We excluded
patients with no smoking status available.
Our ﬁrst model adjusted for age, sex, socioeconomic status at
practice level, and date prior to or post April 1, 2004, when
Quality Outcomes Framework guidelines introduced ﬁnancial in-
centives for recording CKD status among people with diabetes in
primary care that are suggested to have improved ascertainment of
CKD in primary care.31 Our second model additionally adjusted
for confounding by smoking status and comorbid conditions. This
second model was run both with all variables assessed at baseline
and separately with new onset of comorbid condition time updated
during the study (but not smoking status because changes in
smoking status are particularly vulnerable to reverse causation).
Our ﬁnal model additionally adjusted for hemoglobin A1c level
and diabetic medication history at baseline. All nonbinary cova-
riates were modeled as categorical variables.
Sensitivity analyses repeated the ﬁnal model with the following
adjustments: limiting follow-up to post April 1, 2004; restricting
the data set to patients with HES linkage available; and using only
the ﬁrst infection as an outcome.
All estimates for the associations of eGFR with infection were
adjusted for proteinuria, and vice versa, so that the effect estimates
for eGFR and proteinuria are independent.
We looked for evidence of interaction between eGFR and
proteinuria and between eGFR and age (65-74 and $75 years) in
the ﬁnal models for LRTI and pneumonia using likelihood ratio
tests to assess nested models with and without interaction terms.
We did not look for interaction in the sepsis regression model due
to the smaller number of events.
Stata, version 13.1 (StataCorp LP), was used for data analyses.
All code lists are available on request.Am J Kidney Dis. 2015;66(1):60-68Ethics Approval
The study was approved by the Independent Scientiﬁc Advisory
Committee of the CPRD (ISAC reference 11_033A) and the
London School of Hygiene & Tropical Medicine Ethics Com-
mittee (LSHTM reference 6116).
RESULTS
Of 218,211 patients potentially eligible for inclu-
sion, 191,709 (87.9%) had a valid serum creatinine
result and complete data available (Fig 1). Study
participants were followed up for a median of 4.6
(interquartile range [IQR], 2.3-7.6) years. Median age
at study entry was 71 (IQR, 66-78) years. For 113,106
study participants (59.0%), HES linkage was avail-
able. The population with no available serum creati-
nine result had a high prevalence of missing data for
both smoking status (2,760 of 24,738 [11.2%]) and
hemoglobin A1c results (10,866 of 24,739 [43.9%]),
suggesting that this population may not attend pri-
mary care services frequently. The population with no
available creatinine result had a comorbid condition
proﬁle similar to patients with CKD stages 3 to 5 in
terms of prevalence of congestive heart failure and
cerebrovascular disease (Table 1).
We found good completeness of serum creatinine
result recording: only 11% of potentially eligible pa-
tients lacked a valid serum creatinine result (Fig 1). The
median time for which each creatinine result was car-
ried forward was 137 (IQR, 56-242) days. At study
entry, 67,859 (35.4%) participants had CKD stages 3 to
5, deﬁned as eGFR, 60 mL/min/1.73 m2, and 25,433
(13.3%) had a history of proteinuria (Table 2).25
We observed 115,080 LRTIs among 56,076 pa-
tients, 7,870 episodes of pneumonia among 7,095
patients, and 1,980 episodes of sepsis among 1,902
patients. Crude incidence rates were as follows:
LRTI, 155.8 (95% conﬁdence interval [CI], 154.3-
157.4)/1,000 person-years; pneumonia, 10.3 (95% CI,63
Table 3. Infection Rates With Corresponding Rate Ratios by eGFR
Infection
No. of
Events
Time at
Risk
(person-y)
Crude Rate/1,000
Person-y (95% CI)
Minimally
Adjusteda,b
Adjusted for
Comorbid
Conditions
at Baselineb,c
Adjusted for
Time-Updated
Comorbid
Conditionsb,d
Adjusted for
Characteristics
of Diabetesb,e
LRTI 115,080 808,194 155.8 (154.3-157.4)
eGFR, 15 607 2,532 295.3 (265.8-324.8) 1.78 (1.61-1.96) 1.67 (1.51-1.85) 1.52 (1.38-1.68) 1.47 (1.34-1.62)
eGFR 15-29 5,153 25,016 228.0 (219.8-236.2) 1.38 (1.33-1.43) 1.28 (1.23-1.33) 1.20 (1.15-1.24) 1.17 (1.13-1.22)
eGFR 30-44 16,557 96,214 188.7 (184.8-192.6) 1.19 (1.16-1.22) 1.13 (1.10-1.15) 1.09 (1.07-1.12) 1.08 (1.05-1.10)
eGFR 45-59 29,783 204,866 159.9 (157.4-162.4) 1.06 (1.05-1.08) 1.04 (1.03-1.06) 1.03 (1.02-1.05) 1.03 (1.01-1.04)
eGFR$ 60 62,980 479,565 143.0 (141.3-144.7) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
Pneumoniaf 7,870 816,517 10.3 (10.1-10.6)
eGFR, 15 99 2,570 52.8 (40.7-65.0) 4.26 (3.37-5.38) 3.69 (2.92-4.65) 3.25 (2.58-4.10) 3.04 (2.42-3.83)
eGFR 15-29 650 25,362 30.6 (27.8-33.3) 2.29 (2.07-2.53) 2.01 (1.82-2.23) 1.82 (1.65-2.01) 1.73 (1.57-1.92)
eGFR 30-44 1,523 97,360 17.4 (16.4-18.4) 1.42 (1.33-1.53) 1.31 (1.22-1.40) 1.23 (1.15-1.32) 1.19 (1.11-1.28)
eGFR 45-59 1,980 207,025 10.2 (9.7-10.7) 1.01 (0.95-1.07) 0.98 (0.93-1.04) 0.96 (0.91-1.02) 0.95 (0.89-1.01)
eGFR$ 60 3,618 484,200 7.8 (7.6-8.1) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
Sepsis 1,980 816,826 2.5 (2.4-2.6)
eGFR, 15 41 2,572 17.8 (11.8-23.9) 7.40 (5.19-10.55) 6.93 (4.86-9.90) 6.19 (4.34-8.82) 5.56 (3.90-7.94)
eGFR 15-29 186 25,382 8.1 (6.8-9.3) 3.29 (2.75-3.94) 3.01 (2.52-3.61) 2.69 (2.25-3.23) 2.50 (2.08-3.00)
eGFR 30-44 387 97,416 4.2 (3.7-4.6) 1.80 (1.58-2.06) 1.70 (1.49-1.95) 1.60 (1.39-1.83) 1.51 (1.32-1.73)
eGFR 45-59 499 207,103 2.5 (2.2-2.7) 1.19 (1.06-1.34) 1.17 (1.04-1.32) 1.14 (1.02-1.29) 1.11 (0.99-1.25)
eGFR$ 60 867 484,352 1.8 (1.7-2.0) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
Note: Unless otherwise indicated, values are given as rate ratio (95% CI). eGFR categories expressed in mL/min/1.73 m2.
Abbreviations: CI, confidence interval; eGFR, estimated glomerular filtration rate; LRTI, lower respiratory tract infection.
aAdjusted for proteinuria (updated), age (updated), sex, socioeconomic status by practice, and financial year prior to or post 2004.
bP , 0.001 for all rate ratios. Likelihood ratio test for inclusion of eGFR as a categorical variable in the model.
cAdjusted for proteinuria (updated), age (updated), sex, socioeconomic status by practice, financial year prior to or post 2004,
ischemic heart disease, congestive cardiac failure, hypertension, cerebrovascular disease, other dementia, chronic lung disease, and
smoking at baseline.
dAdjusted for proteinuria (updated), age (updated), sex, socioeconomic status by practice, financial year prior to or post 2004,
ischemic heart disease (updated), congestive cardiac failure (updated), hypertension (updated), cerebrovascular disease (updated),
other dementia (updated), chronic lung disease (updated), and smoking (baseline).
eAdjusted for proteinuria (updated), age (updated), sex, socioeconomic status by practice, financial year prior to or post 2004,
ischemic heart disease (updated), congestive cardiac failure (updated), hypertension (updated), cerebrovascular disease (updated),
other dementia (updated), chronic lung disease (updated), smoking (baseline), hemoglobin A1c level (baseline), and antidiabetes
medication history (baseline).
fSubset of LRTI.
McDonald et al10.1-10.6)/1,000 person-years; and sepsis, 2.5 (95%
CI, 2.4-2.6)/1,000 person-years (Table 3).
Both eGFR and proteinuria were independent risk
markers for incidence of LRTI, pneumonia, and sepsis
(P , 0.001 for each analysis). A high incidence of
infection was observed among patients with CKD. For
example, crude LRTI rates were 228.0 (95% CI,
219.8-236.2)/1,000 person-years among patients with
eGFRs of 15 to 29 mL/min/1.73 m2 compared to 143.0
(95% CI, 141.3-144.7)/1,000 person-years among pa-
tients with eGFRs $ 60 mL/min/1.73 m2. The associ-
ation between eGFR and infection incidence was
graded, with increased infection incidence even at
early stages of CKD. Strong and graded associations
between reduced eGFR and infection remained after
adjustment for age, sex, smoking status, comorbid
conditions, and characteristics of diabetes. Compared
to eGFR $ 60 mL/min/1.73 m2, fully adjusted inci-
dence rate ratios (IRRs) for pneumonia were 3.04 (95%
CI, 2.42-3.83), 1.73 (95% CI, 1.57-1.92), 1.19 (95%64CI, 1.11-1.28), and 0.95 (95% CI, 0.89-1.01) for
eGFRs , 15, 15 to 29, 30 to 44, and 45 to 59 mL/min/
1.73 m2, respectively. The associations between
reduced eGFR and sepsis were stronger, with fully
adjusted IRRs up to 5.56 (95% CI, 3.90-7.94), while
those with LRTI were less strong but still clinically
relevant, with fully adjusted IRRs up to 1.47 (95% CI,
1.34-1.62; Table 3). Fully adjusted rates and rate ratios
using patients with eGFRs of 75 to 89 mL/min/1.73 m2
as a reference group suggested a J-shaped relationship
between eGFR and LRTI and pneumonia incidence
(Fig 2; Table S1 [available as online supplementary
material]).
Proteinuria was an independent risk marker for
infection incidence after adjustment for eGFR
(Table 4). In minimally adjusted analyses, patients
with a history of proteinuria had a higher incidence of
LRTI, pneumonia, and sepsis (IRRs of 1.13 [95% CI,
1.10-1.15], 1.37 [95% CI, 1.30-1.45], and 1.44 [95%
CI, 1.30-1.59], respectively) compared with patientsAm J Kidney Dis. 2015;66(1):60-68
Figure 2. Fully adjusted infection rates/1,000 person-years
(with 95% confidence intervals) against category of estimated
glomerular filtration rate, by proteinuria status. Solid line, pa-
tients with a history of proteinuria; dashed line, patients with
no history of proteinuria. Rates adjusted for age (updated),
sex, socioeconomic status by practice, financial year prior to or
post 2004, ischemic heart disease (updated), congestive cardiac
failure (updated), hypertension (updated), cerebrovascular dis-
ease (updated), other dementia (updated), chronic lung disease
(updated), smoking (baseline), hemoglobin A1c level (baseline),
and antidiabetes medication history (baseline). *LRTI y-axis
scale is 10-fold greater than the pneumonia and sepsis scales.
CKD and Infection Incidencewithout a history of proteinuria. These associations
were diminished but persisted after adjustment for
time-updated comorbid conditions and characteristics
of diabetes for LRTI, pneumonia, and sepsis (IRRs of
1.07 [95% CI, 1.05-1.09], 1.26 [95% CI, 1.19-1.33],
and 1.33 [95% CI, 1.20-1.47], respectively). The effect
of proteinuria did not vary by eGFR category (Fig 2).
No clinically important interaction between age
and eGFR was observed for LRTI or pneumonia.
Sensitivity analyses limiting follow-up to post AprilAm J Kidney Dis. 2015;66(1):60-682004, restricting the data set to patients with HES
linkage available, or using only the ﬁrst infection
as an outcome found similar results to the main
analysis.
DISCUSSION
In our study population of older patients with dia-
betes, there was a high burden of community-acquired
LRTI, pneumonia, and sepsis among those with CKD
(manifested as reduced eGFR and/or history of pro-
teinuria). Reduced eGFR and history of proteinuria
represented independent risk markers for incidence of
LRTI, pneumonia, and sepsis. Associations between
eGFR and infection incidence were graded, with
increased infection incidence at more severe stages of
CKD. These associations persisted after adjustment
for comorbid conditions, smoking status, and char-
acteristics of diabetes mellitus. The association be-
tween eGFR and infection was not modiﬁed by age.
Effect sizes were larger for sepsis than for pneumonia,
and for pneumonia than for LRTI.
The strengths of the study include the following:
ﬁrst, consideration of both eGFR and proteinuria in
mutually adjusted analyses; second, frequent moni-
toring of serum creatinine and proteinuria, allowing
good ascertainment of CKD status; third, the detailed
methods used to deﬁne infections, including exclu-
sion of time in hospital from time at risk and treating
recurrent consultations for infection within 28 days as
a single episode; and fourth, inclusion of infections
managed in primary care, not just those resulting in
hospitalization or death.
The study is limited by the nature of routinely
collected data; we may have underascertained pro-
teinuria or comorbid conditions. The high prevalence
of proteinuria and comorbid conditions observed in
the study population suggests that neither is an
extensive problem. Proteinuria monitoring has been
ﬁnancially incentivized in primary care for this pop-
ulation since 2004.32 A small percentage of the po-
tential study population had no available creatinine
results and therefore were not included. These people
did not appear to seek regular care, which may have
led to us underestimating the association between
CKD and infection. We do not have formal validation
study data for our outcomes, but the advantage of
linked data is capturing a more complete ascertain-
ment of infections than in the stand-alone data sets
used previously.
The complex relationships between CKD, infec-
tion, and cardiovascular disease limit interpretation
of the direction of any causal association between
CKD and infection. The same comorbid conditions,
such as cardiovascular events, may both cause and be
caused by CKD. Adjustment for baseline comorbid
conditions risks underestimation of the association65
Table 4. Infection Rates With Corresponding Rate Ratios by Proteinuria Status
Infection
No. of
Events
Time at
Risk
(person-y)
Crude Rate/1,000
Person-y (95% CI)
Minimally
Adjusteda,b
Adjusted for
Comorbid
Conditions
at Baselineb,c
Adjusted for
Time-Updated
Comorbid
Conditionsb,d
Adjusted for
Characteristics
of Diabetesb,e
LRTI 115,080 808,194 155.8 (154.3-157.4)
Proteinuria 31,823 202,658 178.7 (175.7-181.8) 1.13 (1.10-1.15) 1.15 (1.13-1.17) 1.09 (1.07-1.11) 1.07 (1.05-1.09)
No proteinuria 83,257 605,536 148.9 (147.3-150.5) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
Pneumoniaf 7,870 816,517 10.3 (10.1-10.6)
Proteinuria 2,646 204,908 14.4 (13.8-15.1) 1.37 (1.30-1.45) 1.40 (1.33-1.48) 1.31 (1.24-1.39) 1.26 (1.19-1.33)
No proteinuria 5,224 611,609 9.0 (8.8-9.3) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
Sepsis 1,980 816,826 2.5 (2.4-2.6)
Proteinuria 712 205,002 3.6 (3.3-3.9) 1.44 (1.30-1.59) 1.46 (1.32-1.61) 1.41 (1.27-1.56) 1.33 (1.20-1.47)
No proteinuria 1,268 611,824 2.1 (2.0-2.2) 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
Note: Unless otherwise indicated, values are given as rate ratio (95% CI).
Abbreviations: CI, confidence interval; eGFR, estimated glomerular filtration rate; LRTI, lower respiratory tract infection.
aAdjusted for eGFR (updated), age (updated), sex, socioeconomic status by practice, and financial year prior to or post 2004.
bP , 0.001 for all rate ratios. Likelihood ratio test for inclusion of eGFR as a binary variable in the model.
cAdjusted for eGFR (updated), age (updated), sex, socioeconomic status by practice, financial year prior to or post 2004, ischemic
heart disease, congestive cardiac failure, hypertension, cerebrovascular disease, other dementia, chronic lung disease, and smoking
at baseline.
dAdjusted for eGFR (updated), age (updated), sex, socioeconomic status by practice, financial year prior to or post 2004, ischemic
heart disease (updated), congestive cardiac failure (updated), hypertension (updated), cerebrovascular disease (updated), other
dementia (updated), chronic lung disease (updated), and smoking (baseline).
eAdjusted for eGFR (updated), age (updated), sex, socioeconomic status by practice, financial year prior to or post 2004, ischemic
heart disease (updated), congestive cardiac failure (updated), hypertension (updated), cerebrovascular disease (updated), other
dementia (updated), chronic lung disease (updated), smoking (baseline), hemoglobin A1c level (baseline), and antidiabetes medication
history (baseline).
fSubset of LRTI.
McDonald et albetween CKD and infection by residual confounding
from new-onset comorbid conditions that may reﬂect
baseline risk factors for these comorbid conditions,
such as poorly treated hypertension prior to CKD.
Adjustment for time-updated comorbid conditions is
vulnerable to overadjusting for events that mediate
any effect of CKD on infection. We present both
models. The true association between CKD and
infection is likely to lie between the 2 results. We
avoided time-updating hemoglobin A1c levels and
smoking status because these are vulnerable to reverse
causality from infection (eg, pneumonia may motivate
smoking cessation). We also addressed the risk of
reverse causality by conducting a sensitivity analysis
in which we limited follow-up to the ﬁrst infection,
which found results similar to the main analysis. We
did not adjust for vaccination status because inter-
relationships between CKD status, receipt of vacci-
nation, and infection are likely to be complex and
looking formally for vaccine effectiveness was
beyond the scope of this report.
Our results may not be generalizable to the gen-
eral population without diabetes because there may
be a particular relationship between CKD and
infection among older people with diabetes. How-
ever, older people with diabetes are a large and
growing population with a high burden of CKD and66infection, and so our ﬁndings in this population are
important.
The associations we observed of preexisting eGFR
with sepsis and pneumonia were similar to those
observed between eGFR with bloodstream infections
and pneumonia diagnoses in hospital records among
the general population 65 years and older (although
different outcome deﬁnitions mean the absolute rates
are not comparable).3,5 A large case-control study in
the United Kingdom identiﬁed CKD as a risk factor
for primary care diagnosis of pneumonia (adjusted
odds ratio, 1.72; 95% CI, 1.3-2.07), but the unclear
deﬁnition of CKD may have included patients with an
increased risk of infection from renal replacement
therapy and did not permit stage-speciﬁc rate ratios.9
James et al3 and Dalrymple et al33 observed a J-
shaped association between eGFR and infection
risk, which was not present using cystatin C–based
eGFR. Our results suggested that patients with
eGFRs $ 90 mL/min/1.73 m2 had a slightly increased
risk of LRTI or pneumonia compared with those with
eGFRs of 75 to 89 mL/min/1.73 m2, but we did not
observe a J shape for the association of eGFR with
sepsis. James et al found that the association of eGFR
with hospitalization for pneumonia was weaker
among older age groups.3 We did not observe an
interaction between eGFR and age in the presentAm J Kidney Dis. 2015;66(1):60-68
CKD and Infection Incidencestudy, which may be due partly to our study popu-
lation being limited to older people. In a previous
study identifying albuminuria as a risk factor for
infection-related hospitalization among patients with
diabetes, eGFR was not an independent risk marker
for infection, and infections managed in primary
care were not included.6 To our knowledge, our
ﬁnding that proteinuria is a risk marker for incidence
of LRTI, pneumonia, and sepsis, independently of
eGFR, and including infections managed in primary
care, is novel.
This study found that the associations of reduced
eGFR and history of proteinuria with infection
appeared to be due in part to underlying accrued
cardiovascular and cerebrovascular comorbid condi-
tions, but a strong graded association remained after
adjustment for these. It has been suggested that CKD
as a risk marker for infection may be a surrogate for
chronicity of diabetes or poor glycemic control.6
Adjustments for cardiovascular and cerebrovascular
comorbid conditions will reﬂect chronicity and
severity of diabetes to a certain extent, but further
adjustment for severity and control of diabetes had
little effect on the associations between CKD and
infection, suggesting that the associations between
CKD and infections are not explained fully by these
factors. Stronger independent associations with CKD
were observed for pneumonia than LRTI, and stron-
ger still for sepsis, consistent with a view of CKD as a
risk factor for poorer prognosis and greater incidence
of infection. For clinicians managing older people
with diabetes, our ﬁndings may help identify patients
at increased risk of infection and inform discussions
about infection risk and vaccination.30 For policy
makers, the association of CKD with a high burden of
morbidity from infection is important for health ser-
vice planning because the populations with diabetes
and CKD are predicted to grow.34
Several unanswered questions remain. More
research is needed to identify the biological mecha-
nisms underlying the associations of proteinuria and
eGFR with infection and to improve infection pre-
vention strategies. For example, better understanding
of vaccine effectiveness among people with CKD
could inform whether pneumococcal and inﬂuenza
vaccination recommendations should include people
with proteinuria.35
ACKNOWLEDGEMENTS
Support: Dr Thomas reports a Career Development Fellowship
grant (CDF 2010-03-32) from the National Institute for Health
Research during the conduct of the study. Dr McDonald reports a
PhD studentship grant from Kidney Research UK (grant reference
ST2/2011) during the conduct of the study, for which Drs Thomas
and Nitsch wrote the studentship application. The study sponsors
had no role in the design or conduct of the study; the collection,
management, analysis, or interpretation of data; the preparation,Am J Kidney Dis. 2015;66(1):60-68review, or approval of the manuscript; or the decision to submit it
for publication. The views expressed in this publication are those
of the authors and not necessarily those of the UK National Health
Service, the National Institute for Health Research, the Department
of Health, or Kidney Research UK.
Financial Disclosure: Dr Nitsch reports subcontract work for
grants received by BMJ Informatica for the Healthcare Quality
Improvement Partnership national CKD audit. The remaining
authors declare that they have no other relevant ﬁnancial interests.
Contributions: Research idea and study design: HIM, SLT,
ERCM, DN; data acquisition: SLT; data analysis/interpretation:
HIM, SLT, ERCM, DN; statistical analysis: HIM, ERCM; su-
pervision or mentorship: SLT, DN. Each author contributed
important intellectual content during manuscript drafting or revi-
sion and accepts accountability for the overall work by ensuring
that questions pertaining to the accuracy or integrity of any portion
of the work are appropriately investigated and resolved. HIM takes
responsibility that this study has been reported honestly, accu-
rately, and transparently; that no important aspects of the study
have been omitted; and that any discrepancies from the study as
planned have been explained.
SUPPLEMENTARY MATERIAL
Table S1: Sensitivity analysis of association between eGFR and
infection incidence.
Note: The supplementary material accompanying this article
(http://dx.doi.org/10.1053/j.ajkd.2014.11.027) is available at
www.ajkd.org
REFERENCES
1. Bardsley M, Blunt I, Davies S, Dixon J. Is secondary pre-
ventive care improving? Observational study of 10-year trends in
emergency admissions for conditions amenable to ambulatory
care. BMJ Open. 2013;3(1):e002007.
2. Trotter CL, Stuart JM, George R, Miller E. Increasing hos-
pital admissions for pneumonia, England. Emerg Infect Dis.
2008;14(5):727-733.
3. James MT, Quan H, Tonelli M, et al. CKD and risk of
hospitalization and death with pneumonia. Am J Kidney Dis.
2009;54(1):24-32.
4. Collins AJ, Foley RN, Herzog C, et al. US Renal Data System
2010 Annual Data Report. Am J Kidney Dis. 2011;57(1)(suppl 1):
A8, e1-e526.
5. James MT, Laupland KB, Tonelli M, Manns BJ,
Culleton BF, Hemmelgarn BR. Risk of bloodstream infection in
patients with chronic kidney disease not treated with dialysis. Arch
Intern Med. 2008;168(21):2333-2339.
6. Hamilton EJ, Martin N,Makepeace A, Sillars BA, DavisWA,
Davis TM. Incidence and predictors of hospitalization for bacterial
infection in community-based patients with type 2 diabetes: the
Fremantle Diabetes Study. PLoS One. 2013;8(3):e60502.
7. Karunajeewa H, McGechie D, Stuccio G, Stingemore N,
Davis WA, Davis TM. Asymptomatic bacteriuria as a predictor of
subsequent hospitalisation with urinary tract infection in diabetic
adults: the Fremantle Diabetes Study. Diabetologia. 2005;48(7):
1288-1291.
8. Viasus D, Garcia-Vidal C, Cruzado JM, et al. Epidemiology,
clinical features and outcomes of pneumonia in patientswith chronic
kidney disease. Nephrol Dial Transplant. 2011;26(9):2899-2906.
9. Vinogradova Y, Hippisley-Cox J, Coupland C. Identiﬁcation
of new risk factors for pneumonia: population-based case-control
study. Br J Gen Pract. 2009;59(567):e329-e338.
10. New JP, Middleton RJ, Klebe B, et al. Assessing the
prevalence, monitoring and management of chronic kidney disease67
McDonald et alin patients with diabetes compared with those without diabetes in
general practice. Diabet Med. 2007;24(4):364-369.
11. De Lusignan S. Identiﬁcation and management of chronic
kidney disease. Prescriber. 2008;19(10):10-18.
12. Collins AJ, Foley RN, Chavers B. United States Renal Data
System 2011 annual data report: atlas of chronic kidney disease
and end-stage renal disease in the United States. Am J Kidney Dis.
2012;59(1)(suppl 1):e1-e420.
13. The NHS Information Centre Prescribing and Primary Care
Services. Quality and Outcomes Framework Achievement Data
2010/11. Leeds, UK: The NHS Information Centre; 2011.
14. Campbell SM, Reeves D, Kontopantelis E, Sibbald B,
Roland M. Effects of pay for performance on the quality of pri-
mary care in England. N Engl J Med. 2009;361(4):368-378.
15. McDonald HI, Nitsch D, Millett ER, Sinclair A,
Thomas SL. New estimates of the burden of acute community-
acquired infections among older people with diabetes mellitus: a
retrospective cohort study using linked electronic health records.
Diabet Med. 2013;31(5):606-614.
16. Holman N, Forouhi NG, Goyder E, Wild SH. The Asso-
ciation of Public Health Observatories (APHO) diabetes preva-
lence model: estimates of total diabetes prevalence for England,
2010-2030. Diabet Med. 2011;28(5):575-582.
17. Finlay S, Bray B, Lewington AJ, et al. Identiﬁcation of risk
factors associated with acute kidney injury in patients admitted to
acute medical units. Clin Med. 2013;13(3):233-238.
18. CPRD. The Clinical Practice Research Datalink-CPRD.
2012. http://www.cprd.com/intro.asp. Accessed August 30, 2012.
19. Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ.
Validation and validity of diagnoses in the General Practice
Research Database: a systematic review. Br J Clin Pharmacol.
2010;69(1):4-14.
20. Walley T, Mantgani A. The UK General Practice Research
Database. Lancet. 1997;350(9084):1097-1099.
21. The Health and Social Care Information Centre. HESonline.
2012. http://www.hscic.gov.uk/hes. Accessed September 14, 2012.
22. Ofﬁce for National Statistics. 2012. www.ons.gov.uk.
Accessed September 14, 2012.
23. Levey AS, Stevens LA, Schmid CH, et al. A new equation
to estimate glomerular ﬁltration rate. Ann Intern Med.
2009;150(9):604-612.
24. Matsushita K, Mahmoodi BK, Woodward M, et al. Com-
parison of risk prediction using the CKD-EPI equation and the68MDRD Study equation for estimated glomerular ﬁltration rate.
JAMA. 2012;307(18):1941-1951.
25. National Kidney Foundation: K/DOQI clinical practice
guidelines for chronic kidney disease: evaluation, classiﬁcation,
and stratiﬁcation. Am J Kidney Dis. 2002;39(2)(suppl 1):
S1-S266.
26. Mathur R, Bhaskaran K, Chaturvedi N, et al. Completeness
and usability of ethnicity data in UK-based primary care and
hospital databases. J Public Health (Oxf). 2014;36(4):684-692.
27. de Lusignan S, Tomson C, Harris K, van Vlymen J,
Gallagher H. Creatinine ﬂuctuation has a greater effect than the
formula to estimate glomerular ﬁltration rate on the prevalence of
chronic kidney disease. Nephron Clin Pract. 2011;117(3):
c213-c224.
28. Millett ER, Quint JK, Smeeth L, Daniel RM, Thomas SL.
Incidence of community-acquired lower respiratory tract infections
and pneumonia among older adults in the United Kingdom: a
population-based study. PLoS One. 2013;8(9):e75131.
29. Ferguson J, Bauld L, Chesterman J, Judge K. The English
smoking treatment services: one-year outcomes. Addiction.
2005;100(suppl 2):59-69.
30. Anandarajah S, Tai T, de Lusignan S, et al. The validity of
searching routinely collected general practice computer data to
identify patients with chronic kidney disease (CKD): a manual
review of 500 medical records. Nephrol Dial Transplant.
2005;20(10):2089-2096.
31. Hobbs H, Stevens P, Klebe B, et al. Referral patterns to
renal services: what has changed in the past 4 years? Nephrol Dial
Transplant. 2009;24(11):3411-3419.
32. NHS Employers. Quality and outcomes framework. 2012.
http://www.nhsemployers.org/payandcontracts/generalmedical
servicescontract/qof/pages/qualityoutcomesframework.aspx. Accessed
September 12, 2012.
33. Dalrymple LS, Katz R, Kestenbaum B, et al. The risk of
infection-related hospitalization with decreased kidney function.
Am J Kidney Dis. 2012;59(3):356-363.
34. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY.
Chronic kidney disease and the risks of death, cardiovascular
events, and hospitalization. N Engl J Med. 2004;351(13):1296-
1305.
35. Kausz AT, Gilbertson DT. Overview of vaccination in
chronic kidney disease. Adv Chronic Kidney Dis. 2006;13(3):
209-214.Am J Kidney Dis. 2015;66(1):60-68
